NASDAQ:EPIX
Delisted

Essa Pharma Stock Insider Trading

etoro logo Buy EPIX
*Your capital is at risk
$0.201
+0 (+0%)
At Close: Jan 12, 2026

ESSA Pharma Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -100.00. In total, the insiders bought 8.59M and sold 19.43M EPIX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-100.00
Buy 8.59M shares
Sell 19.43M shares
48% Buy Activity
Moderate Positive Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Aug 05, 2025
Buy
Common Stock
X-InTheMoney
Bvf Partners L P/il
10 Percent Owner
10% Owner 203 336
Value: $20
Aug 05, 2025
Sell
Common Stock
S-Sale
Bvf Partners L P/il
10 Percent Owner
10% Owner 66
Value: $124
Aug 05, 2025
Buy
Common Stock
X-InTheMoney
Bvf Partners L P/il
10 Percent Owner
10% Owner 1 235 030
Value: $124
Aug 05, 2025
Sell
Common Stock
S-Sale
Bvf Partners L P/il
10 Percent Owner
10% Owner 79
Value: $148
Aug 05, 2025
Buy
Common Stock
X-InTheMoney
Bvf Partners L P/il
10 Percent Owner
10% Owner 1 481 634
Value: $148
Nov 01, 2024
Sell
Common Shares
S-Sale
Biotech Growth N V
10 Percent Owner
10% Owner 2 000 000
Value: $3.06M
Nov 01, 2024
Sell
Common Shares
S-Sale
Biotech Growth N V
10 Percent Owner
10% Owner 2 000 000
Value: $3.05M
Nov 01, 2024
Sell
Common Shares
S-Sale
Biotech Growth N V
10 Percent Owner
10% Owner 2 000 000
Value: $3.06M
Nov 01, 2024
Sell
Common Shares
S-Sale
Biotech Growth N V
10 Percent Owner
10% Owner 1 879 583
Value: $2.84M
Nov 01, 2024
Sell
Common Shares
S-Sale
Biotech Growth N V
10 Percent Owner
10% Owner 1 879 583
Value: $2.84M
Nov 01, 2024
Sell
Common Shares
S-Sale
Biotech Growth N V
10 Percent Owner
10% Owner 2 000 000
Value: $3.06M
Nov 01, 2024
Sell
Common Shares
S-Sale
Biotech Growth N V
10 Percent Owner
10% Owner 2 000 000
Value: $3.05M
Nov 01, 2024
Sell
Common Shares
S-Sale
Biotech Growth N V
10 Percent Owner
10% Owner 2 000 000
Value: $3.06M
Sep 09, 2024
Sell
Common Shares
S-Sale
Virsik Peter
Chief Operating Officer
C-Suite Officer 694
Value: $4K
Sep 09, 2024
Sell
Common Shares
S-Sale
Virsik Peter
Chief Operating Officer
C-Suite Officer 694
Value: $4K
Sep 03, 2024
Sell
Common Shares
S-Sale
Virsik Peter
Chief Operating Officer
C-Suite Officer 2 082
Value: $12.6K
Sep 03, 2024
Sell
Common Shares
S-Sale
Virsik Peter
Chief Operating Officer
C-Suite Officer 2 082
Value: $12.6K
May 06, 2024
Sell
Common Shares
S-Sale
Virsik Peter
Chief Operating Officer
C-Suite Officer 694
Value: $5K
May 06, 2024
Sell
Common Shares
S-Sale
Virsik Peter
Chief Operating Officer
C-Suite Officer 694
Value: $5K
Apr 24, 2024
Buy
Common Shares
M-Exempt
Glickman Richard M
Director
Director 3 750
Value: $18.4K
Apr 24, 2024
Buy
Options
M-Exempt
Glickman Richard M
Director
Director 3 750
Value: $18.4K
Apr 24, 2024
Buy
Options
M-Exempt
Glickman Richard M
Director
Director 3 750
Value: $18.4K
Apr 24, 2024
Buy
Common Shares
M-Exempt
Glickman Richard M
Director
Director 3 750
Value: $18.4K
Apr 05, 2024
Sell
Common Shares
S-Sale
Virsik Peter
Chief Operating Officer
C-Suite Officer 694
Value: $6K
Apr 05, 2024
Sell
Common Shares
S-Sale
Virsik Peter
Chief Operating Officer
C-Suite Officer 694
Value: $6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ESSA PHARMA INC.
ESSA Pharma
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and A...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
4.43% Jun 01
N
NVRI
$19.53
0.87% May 20
RUN
$12.83
15.51% May 06
GLBE
$31.61
4.05% May 05
SAP
$172.39
8.56% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE